Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3390/cells11152403
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2022
- Urheber
- DOI
-
10.18154/RWTH-CONV-249685
- URN
-
urn:nbn:de:101:1-2023040206331460008454
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weiskirchen, Ralf
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2022
Ähnliche Objekte (12)
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Cell therapy in liver fibrosis
Magnetic-assisted treatment of liver fibrosis
Established Hepatic Stellate Cell Lines in Hepatology Research
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Special Issue "Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment"